Skip to main content
. 2015 Nov 19;35(6):697–708. doi: 10.1007/s40846-015-0087-7

Table 3.

Effectiveness rates and RRs between combination therapies and three monotherapies as found in literature

No. of TBs Effective TBs Effective rate (%) Effective 95 % CI (%) RR between combination therapies and others
On combination therapies (pooled) 437 264 60.4 55.8–65.0
On DPA monotherapy [15] 99 73 73.7 65.1–82.4 0.82
On TETA monotherapy [37] 109 90 82.6 75.4–89.7 0.73
On zinc monotherapy [16] 88 63 71.6 62.2–81.0 0.84

TBs treatment blocks, CI confidence interval, RR relative risk ratio, DPA penicillamine, TETA trientine